DE602006009524D1 - Neue camptothecin-analoga-verbindungen, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Neue camptothecin-analoga-verbindungen, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE602006009524D1
DE602006009524D1 DE602006009524T DE602006009524T DE602006009524D1 DE 602006009524 D1 DE602006009524 D1 DE 602006009524D1 DE 602006009524 T DE602006009524 T DE 602006009524T DE 602006009524 T DE602006009524 T DE 602006009524T DE 602006009524 D1 DE602006009524 D1 DE 602006009524D1
Authority
DE
Germany
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
analogue compounds
camptothecin analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006009524T
Other languages
English (en)
Inventor
Gilbert Lavielle
Patrick Hautefaye
Alain Pierre
John Hickman
Stephane Leonce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of DE602006009524D1 publication Critical patent/DE602006009524D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602006009524T 2005-08-05 2006-08-04 Neue camptothecin-analoga-verbindungen, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen Active DE602006009524D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0508365A FR2889528B1 (fr) 2005-08-05 2005-08-05 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2006/001900 WO2007017584A1 (fr) 2005-08-05 2006-08-04 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DE602006009524D1 true DE602006009524D1 (de) 2009-11-12

Family

ID=36216982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006009524T Active DE602006009524D1 (de) 2005-08-05 2006-08-04 Neue camptothecin-analoga-verbindungen, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen

Country Status (30)

Country Link
US (1) US20100168150A1 (de)
EP (1) EP1910376B1 (de)
JP (1) JP2009505963A (de)
KR (1) KR20080032006A (de)
CN (1) CN101233140B (de)
AR (1) AR055596A1 (de)
AT (1) ATE444297T1 (de)
AU (1) AU2006277862A1 (de)
BR (1) BRPI0614522A2 (de)
CA (1) CA2617951A1 (de)
CY (1) CY1110545T1 (de)
DE (1) DE602006009524D1 (de)
DK (1) DK1910376T3 (de)
EA (1) EA014754B1 (de)
ES (1) ES2334263T3 (de)
FR (1) FR2889528B1 (de)
GE (1) GEP20115229B (de)
HK (1) HK1123048A1 (de)
HR (1) HRP20090651T1 (de)
MA (1) MA29648B1 (de)
MX (1) MX2008001559A (de)
NO (1) NO20081157L (de)
NZ (1) NZ565397A (de)
PL (1) PL1910376T3 (de)
PT (1) PT1910376E (de)
RS (1) RS51061B (de)
SI (1) SI1910376T1 (de)
UA (1) UA95254C2 (de)
WO (1) WO2007017584A1 (de)
ZA (1) ZA200801992B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889527A1 (fr) * 2005-08-05 2007-02-09 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801309B1 (fr) * 1999-11-18 2002-01-04 Adir Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6699876B2 (en) * 1999-11-18 2004-03-02 Les Laboratoires Servier Camptothecin analogue compounds
US6403604B1 (en) * 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
AU2003243380A1 (en) * 2002-06-03 2003-12-19 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
CN100443486C (zh) * 2002-09-11 2008-12-17 中国医学科学院药物研究所 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途
FR2889527A1 (fr) * 2005-08-05 2007-02-09 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ATE444297T1 (de) 2009-10-15
ES2334263T3 (es) 2010-03-08
CN101233140B (zh) 2011-05-25
DK1910376T3 (da) 2010-01-11
KR20080032006A (ko) 2008-04-11
EA014754B1 (ru) 2011-02-28
HK1123048A1 (en) 2009-06-05
JP2009505963A (ja) 2009-02-12
HRP20090651T1 (hr) 2010-01-31
FR2889528B1 (fr) 2007-09-07
MX2008001559A (es) 2008-02-15
NZ565397A (en) 2011-06-30
CN101233140A (zh) 2008-07-30
PT1910376E (pt) 2009-11-05
SI1910376T1 (sl) 2010-01-29
PL1910376T3 (pl) 2009-12-31
FR2889528A1 (fr) 2007-02-09
AU2006277862A1 (en) 2007-02-15
EP1910376A1 (de) 2008-04-16
EP1910376B1 (de) 2009-09-30
AR055596A1 (es) 2007-08-29
EA200800392A1 (ru) 2008-08-29
MA29648B1 (fr) 2008-07-01
ZA200801992B (en) 2009-07-29
NO20081157L (no) 2008-03-05
CY1110545T1 (el) 2015-04-29
UA95254C2 (ru) 2011-07-25
BRPI0614522A2 (pt) 2019-04-24
GEP20115229B (en) 2011-06-10
RS51061B (sr) 2010-10-31
US20100168150A1 (en) 2010-07-01
CA2617951A1 (fr) 2007-02-15
WO2007017584A1 (fr) 2007-02-15

Similar Documents

Publication Publication Date Title
ATE389398T1 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
BRPI0511900A (pt) composições farmacêuticas
RU2398586C3 (ru) Фармацевтическая композиция
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
DK3072507T3 (da) Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
BRPI0716495A2 (pt) (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos.
ATE453384T1 (de) Neue dosierformulierung
BRPI0609802A2 (pt) composto, composição farmacêutica e uso de um composto
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
CL2007002376A1 (es) Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas.
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
CL2007003444A1 (es) Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria.
CL2007001630A1 (es) Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
BRPI0614730A2 (pt) composto, composição farmacêutica, e, uso de um composto
ATE483702T1 (de) Neue pharmazeutische verbindungen
DK1587478T3 (da) Farmaceutisk sammensætning
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
EP1845099A4 (de) Artemisin- (qinghaosu-) derivate, verfahren zu deren herstellung und deren verwendung, und diese enthaltende pharmazeutische zusammensetzungen
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
DE602006000102D1 (de) Indanyl-piperazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition